Nuchprayoon I, Sanpavat S, Nuchprayoon S. Glucose-6-phosphate dehydrogenase (G6PD) mutations in Thailand: G6PD Viangchan (871G>A) is the most common deficiency variant in the Thai population. Hum Mutat 2002;19:185.CrossrefPubMedGoogle Scholar
World Health Organization. Guidelines for the treatment of malaria, 3rd ed. Geneva: WHO, 2015:316.Google Scholar
Luzzatto L, Poggi V. Glucose-6-phosphate dehydrogenase deficiency. In: Orkin SH, Nathan DG, Ginsburg D, Look AT, Fisher DE, Lux SE, editor. Nathan and Oski’s hematology of infancy and childhood, 7th ed. Philadelphia, PA: Saunders Elsevier, 2009:883–907.Google Scholar
Beutler E, Blume KG, Kaplan JC, Lohr GW, Ramot B, Valentine WN. International Committee for Standardization in Haematology: recommended screening test for glucose-6-phosphate dehydrogenase (G-6-PD) deficiency. Br J Haematol 1979;43:465–7.PubMedCrossrefGoogle Scholar
Pornprasert S, Tookjai M, Punyamung M, Pongpunyayuen P,Jaiping K. Development of hemoglobin typing control materials for laboratory investigation of thalassemia and hemoglobinopathies. Clin Chem Lab Med 2016;54:81–9.PubMedWeb of ScienceGoogle Scholar
Kahn M, LaRue N, Zhu C, Pal S, Mo JS, Barrett LK, et al. Recombinant human G6PD for quality control and quality assurance of novel point-of-care diagnostics for G6PD deficiency. PLoS One 2017;12:e0177885.Web of SciencePubMedCrossrefGoogle Scholar
About the article
Published Online: 2019-07-11
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.